Page last updated: 2024-12-08
10,12-tricosadiynoic acid
## 10,12-Tricosadiynoic acid (TDA)
**10,12-Tricosadiynoic acid (TDA)** is a naturally occurring fatty acid with two triple bonds at carbons 10 and 12, giving it a distinctive diyne structure. It is found in various plants and microorganisms, notably in certain species of *Chrysanthemum* and *Artemisia*.
**Why is TDA important for research?**
TDA possesses a unique combination of properties that makes it interesting for various fields of research, including:
**1. Biological Activity:**
* **Antimicrobial activity:** TDA has shown significant activity against various bacteria and fungi, potentially serving as a source for new antimicrobial agents.
* **Antifungal activity:** TDA exhibits potent antifungal activity, particularly against the opportunistic fungal pathogen *Candida albicans*.
* **Anti-inflammatory activity:** Some studies suggest that TDA may possess anti-inflammatory properties.
* **Cytotoxicity:** TDA has shown cytotoxicity against certain cancer cell lines, suggesting potential therapeutic applications.
**2. Chemical Properties:**
* **Unique structure:** The diyne structure of TDA contributes to its distinct chemical reactivity and potential for chemical modifications.
* **Self-assembly properties:** TDA has demonstrated self-assembly properties, forming organized structures like nanotubes and micelles. This property makes it promising for applications in materials science.
* **Luminescence:** TDA exhibits luminescence, making it potentially useful for fluorescence-based sensing and imaging applications.
**3. Potential Applications:**
* **Development of novel antibiotics and antifungals:** TDA's antimicrobial properties make it a promising candidate for developing new therapeutic agents to combat resistant pathogens.
* **Nanomaterials and drug delivery:** The self-assembly properties of TDA could lead to the development of novel nanomaterials for targeted drug delivery and controlled release.
* **Bioimaging and diagnostics:** The luminescence of TDA could be harnessed for bioimaging and diagnostic applications.
**Ongoing Research:**
Research on TDA is ongoing in several areas, including:
* Understanding its mechanism of action against microbes and cancer cells.
* Developing new synthetic methods to produce TDA efficiently.
* Exploring its potential applications in various fields, including medicine, materials science, and biotechnology.
**Overall, 10,12-tricosadiynoic acid is a fascinating molecule with unique properties and promising potential for various applications.** Its biological activity, chemical properties, and potential applications make it a subject of continued research and development.
Cross-References
ID Source | ID |
PubMed CID | 538457 |
CHEBI ID | 190947 |
SCHEMBL ID | 302150 |
MeSH ID | M0398414 |
Synonyms (19)
Synonym |
AKOS015839844 |
10,12-tricosadiynoic acid |
10,12-tricosadiynoic acid, >=98.0% (gc) |
66990-30-5 |
T1200 |
tricosa-10,12-diynoic acid |
CHEBI:190947 |
10,12-tricosadiynoicacid |
FT-0607184 |
SCHEMBL302150 |
10,12- tricosadiynoic acid |
mfcd00041683 |
DTXSID40337084 |
CS-0112754 |
HY-135425 |
10,12-tricosadiynoic acid, >/=98% |
d-saccharicacid1,4-lactone |
D92469 |
PD127433 |
Drug Classes (1)
Class | Description |
very long-chain fatty acid | A fatty acid which has a chain length greater than C22. Very long-chain fatty acids which have a chain length greater than C27 are also known as ultra-long-chain fatty acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (57.14) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 23.41 (24.57) | Research Supply Index | 2.71 (2.92) | Research Growth Index | 4.48 (4.65) | Search Engine Demand Index | 23.28 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |